Trials / Completed
CompletedNCT01395849
Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,116 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The purpose of this post-marketing surveillance is to detect adverse drug reactions (particularly clinically significant adverse drug reactions) occurring in clinical settings, to examine factors likely to affect the safety and efficacy in the Japanese asthma patients treated with fluticasone propionate and salmeterol xinafoate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Salmeterol and Fluticasone |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2009-09-01
- Completion
- 2011-03-01
- First posted
- 2011-07-18
- Last updated
- 2017-05-16
Source: ClinicalTrials.gov record NCT01395849. Inclusion in this directory is not an endorsement.